Geant4 Monte Carlo simulation study of the secondary radiation fields at the laser-driven ion source LION.

Autor: Tisi, M.¹ (AUTHOR) marco.tisi@helmholtz-muenchen.de, Mares, V.¹ (AUTHOR), Schreiber, J.^2,3 (AUTHOR), Englbrecht, F. S.² (AUTHOR), Rühm, W.¹ (AUTHOR)

Publikováno v: Scientific Reports. 12/24/2021, Vol. 11 Issue 1, p1-16. 16p.

Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey

Autor: Pagano, Livio, Salmanton-Garcia, J., Marchesi, F., Blennow, O., Gomes da Silva, M., Glenthoj, A., van Doesum, J., Bilgin, Y. M., Lopez-Garcia, A., Itri, F., Nunes Rodrigues, R., Weinbergerova, B., Farina, F., Dragonetti, Giulia, Berg Venemyr, C., van Praet, J., Jaksic, O., Valkovic, T., Falces-Romero, I., Martin-Perez, S., Jimenez, M., Davila-Valls, J., Schonlein, M., Ammatuna, E., Meers, S., Delia, M., Stojanoski, Z., Nordlander, A., Lahmer, T., Imre Pinczes, L., Buquicchio, C., Piukovics, K., Ormazabal-Velez, I., Fracchiolla, N., Samarkos, M., Mendez, G. -A., Hernandez-Rivas, J. -A., Espigado, I., Cernan, M., Petzer, V., Lamure, S., di Blasi, R., Marques de Almedia, J., Dargenio, M., Biernat, M. M., Sciume, M., de Ramon, C., de Jonge, N., Batinic, J., Aujayeb, A., Marchetti, M., Fouquet, G., Fernandez, N., Zambrotta, G., Sacchi, M. V., Guidetti, A., Demirkan, F., Prezioso, L., Racil, Z., Nucci, M., Mladenovic, M., Lievin, R., Hanakova, M., Grafe, S., Sili, U., Machado, M., Cattaneo, C., Adzic-Vukicevic, T., Verga, L., Labrador, J., Rahimli, L., Bonanni, Matteo, Passamonti, F., Pagliuca, A., Corradini, P., Hoenigl, M., Koehler, P., Busca, A., Cornely, O. A., Serrano, L., Ribera-Santa Susana, J. -M., Meletiadis, J., Tsirigotis, P., Coppola, N., Mikulska, M., Erben, N., Besson, C., Merelli, M., Gonzalez-Lopez, T. -J., Loureiro-Amigo, J., Garcia-Vidal, C., Kort, E. D., Cuccaro, A., Zompi, S., Reizine, F., Finizio, O., Dulery, R., Calbacho, M., Abu-Zeinah, G., Malak, S., Zdziarski, P., Varrichio, G., Tragiannidis, A., Plantefeve, G., Duarte, R., Danion, F., Tisi, M. C., Sakellari, I., Karthaus, M., Groh, A., Fung, M., Emarah, Z., Coronel-Ayala, O. -F., Ann Chai, L. Y., Brehon, M., Bonuomo, V., Wolf, D., Wittig, J., Vehreschild, M., Papa, M. V., Neuhann, J., Jimenez-Lorenzo, M. -J., Grothe, J., Gavriilaki, E., Garcia-Sanz, R., Garcia-Pouton, N., El-Ashwah, S. S., Eggerer, M., Cordoba, R., Colak, G. M., Arellano, E.

Publikováno v: Blood, 140(26), 2773-2787. American Society of Hematology
Blood
Volume 140
Issue 26
Blood, vol 140, iss 26
EPICOVIDEHA Survey members 2022, ' Breakthrough COVID-19 in vaccinated patients with hematologic malignancies : results from the EPICOVIDEHA survey ', Blood, vol. 140, no. 26, pp. 2773-2787 . https://doi.org/10.1182/blood.2022017257
Blood, 140(26). AMER SOC HEMATOLOGY
Pagano, L, Salmanton-garcía, J, Marchesi, F, Blennow, O, Gomes Da Silva, M, Glenthøj, A, Van Doesum, J A, Bilgin, Y M, Lopez-garcia, A, Itri, F, Nunes Rodrigues, R, Weinbergerová, B, Farina, F, Dragonetti, G, Berg Venemyr, C, Van Praet, J, Jaksic, O, Valkovic, T, Falces-romero, I, Martin-perez, S, Jiménez, M, Davila-valls, J, Schonlein, M, Ammatuna, E, Meers, S, Delia, M, Stojanoski, Z, Nordlander, A, Lahmer, T, Pinczés, L I, Buquicchio, C, Piukovics, K, Ormazabal-velez, I, Fracchiolla, N S, Samarkos, M, Mendez, G, Hernández-rivas, J, Espigado, I, Cernan, M, Petzer, V, Lamure, S, Di Blasi, R, Marques De Almeida, J, Dargenio, M, Biernat, M M, Sciumè, M, De Ramón, C, De Jonge, N A, Batinic, J, Aujayeb, A, Marchetti, M, Fouquet, G, Fernández Escalada, N, Zambrotta, G P M, Sacchi, M V, Guidetti, A, Demirken, F, Prezioso, L, Racil, Z, Nucci, M, Mladenovic, M, Lievin, R, Hanakova, M, Grafe, S K, Sili, U, Machado, M, Cattaneo, C, Adzic-vukicevic, T, Verga, L, Labrador, J, Rahimli, L, Bonanni, M, Passamonti, F, Pagliuca, A, Corradini, P, Hoenigl, M, Koehler, P, Busca, A & Cornely, O A 2022, ' Breakthrough COVID-19 in vaccinated patients with hematologic malignancies : results from EPICOVIDEHA survey ', Blood, pp. 2773–2787 . https://doi.org/10.1182/blood.2022017257

Limited data are available on breakthrough COVID-19 in patients with hematologic malignancy (HM) after anti–severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination. Adult patients with HM, ≥1 dose of anti-SARS-CoV-2 vaccine, and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46d068f242283040ec3d5be079ebd89c
https://research.vumc.nl/en/publications/c62a76e2-fca2-45ed-a697-f1017ce3b6ec

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells

Autor: Pieta, A. D., Cappuzzello, E., Palmerini, P., Ventura, A., Visentin, A., Astori, G., Chieregato, K., Mozzo, V., Perbellini, O., Tisi, M. C., Trentin, L., Visco, C., Ruggeri, M., Sommaggio, R., Rosato, A.

Publikováno v: Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)
Journal for Immunotherapy of Cancer

Background Patients affected by aggressive B-cell malignancies who are resistant to primary or salvage chemoimmunotherapy have an extremely poor prognosis and limited therapeutic options. Promising therapeutic success has been achieved with the infus

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::ee27a692bb8784a9bf4b40ef6891a05e
http://hdl.handle.net/11562/1051057

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.